Daunorubicin and abdominal pain Patient Reports February 09, 2010

Daunorubicin Side Effects Report #4646223-8
Daunorubicin side effect was reported by a Consumer or non-health professional from on Apr 22, 2005. Male patient, weighting 179.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , febrile neutropenia, orthostatic hypotension. Daunorubicin dosage: 45 MG/M2/DAY, DAYS 1-3, IV. During the same period patient was treated with CYTARABINE, ZOSUQUIDAR TRIHYDROCHLORIDE, NEUPOGEN. Patient recovered.

Daunorubicin Side Effects Report #4704844-8
Daunorubicin side effect was reported by a Pharmacist from on June 13, 2005. Male patient, 65 years of age, weighting 221.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , arrhythmia supraventricular, fatigue, febrile neutropenia, hypotension, pancreatitis, pneumonitis, renal impairment. Daunorubicin dosage: 45MG/M2 OTHER. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4752248-4
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2005. Male patient, weighting 158.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , blood culture positive, diarrhoea, graft versus host disease, hypertension, platelet count decreased, pyrexia. Daunorubicin dosage: unknown. During the same period patient was treated with CYTARABINE, BUSULFAN, CYCLOPHOSPHAMIDE, MESNA, ALLOGENEIC TRANSPLANT. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5139776-7
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 12, 2006. Female patient, child 7 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , bacterial sepsis, caecitis, flatulence, intussusception, nausea , pyrexia. Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE, ASPARAGINASE. Patient recovered.


Daunorubicin Side Effects Report #4733011-7
Daunorubicin side effect was reported by a Health Professional from UNITED STATES on Aug 01, 2005. Male patient, 13 years of age, weighting 204.4 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , blood culture positive, bloody discharge, caecitis, coagulopathy, ecchymosis, enterococcal sepsis, haemodialysis, hyperglycaemia. Daunorubicin dosage: 50 MG Q WEEK INTRAVENOU. During the same period patient was treated with VINCRISTINE, CEFEPIME, VANCOMYCIN, TOBRAMYCIN, ALTERNAGEL, PEPCID, DIFLUCAN. Patient was hospitalized. Patient died on 07/13/2005.

Daunorubicin Side Effects Report #4865089-4
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2005. Male patient, weighting 198.4 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , hypotension, hypoxia, liver function test abnormal, mental status changes, pancreatitis. Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5273551-8
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2007. Female patient, weighting 66.14 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , agitation, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood fibrinogen decreased, blood phosphorus increased, blood potassium increased, blood urea increased. Daunorubicin dosage: 53 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE, CYTARABINE. Patient recovered.

Daunorubicin Side Effects Report #5078644-6
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2006. Female patient, weighting 117.7 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , atrophic vulvovaginitis, constipation , diverticulum, faecal volume increased, haemorrhoids, neutropenia, rectal haemorrhage. Daunorubicin dosage: 270 MG. During the same period patient was treated with DEXAMETHASONE, ELSPAR, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5385279-4
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2007. Female patient, weighting 60.85 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , blood bilirubin increased, jaundice . Daunorubicin dosage: 87 MG. During the same period patient was treated with METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE, CYTARABINE. Patient was hospitalized. Patient recovered.


Daunorubicin Side Effects Report #5393754-1
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2007. Female patient, weighting 60.85 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , jaundice . Daunorubicin dosage: 87 MG. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5668732-5
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2008. Female patient, weighting 117.3 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , neutropenia, peritonitis, small intestinal perforation. Daunorubicin dosage: 80 MG. During the same period patient was treated with METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE, CYTARABINE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5728570-1
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on May 02, 2008. Female patient, weighting 123.9 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , gastrointestinal perforation, pneumoperitoneum. Daunorubicin dosage: 160 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE, CYTARABINE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4611013-9
Daunorubicin side effect was reported by a Consumer or non-health professional from on Mar 16, 2005. Female patient, weighting 130.1 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , caecitis, dialysis , emotional distress, haematocrit decreased, klebsiella infection, multi-organ failure, platelet count decreased. Daunorubicin dosage: unknown. During the same period patient was treated with ELSPAR, PREDNISONE, VINCRISTINE SULPHATE. Patient died on 03/07/2005.

Daunorubicin Side Effects Report #4636444-2
Daunorubicin side effect was reported by a Consumer or non-health professional from on Apr 13, 2005. Male patient, weighting 179.2 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , neutropenia. Daunorubicin dosage: 45 MG/M2 /DAY , DAYS 1-3 IV. During the same period patient was treated with CYTARABINE, ZOSUQUIDAR TRIHYDROCHLORIDE. Patient recovered.